BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 28841223)

  • 1. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
    Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
    Rangarajan K; Simmons G; Manas D; Malik H; Hamady ZZ
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):684-693. PubMed ID: 31761507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
    Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
    J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
    JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC; Altman A; Marmor S; Hui JYC; Denbo JW; Ankeny JS; Jensen EH
    Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.
    Matull WR; Dhar DK; Ayaru L; Sandanayake NS; Chapman MH; Dias A; Bridgewater J; Webster GJ; Bong JJ; Davidson BR; Pereira SP
    Liver Int; 2011 Jan; 31(1):99-107. PubMed ID: 20846273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
    Gholami S; Colby S; Horowitz DP; Guthrie KA; Ben-Josef E; El-Khoueiry AB; Blanke CD; Philip PA; Kachnic LA; Ahmad SA; Rocha FG
    Ann Surg Oncol; 2023 Mar; 30(3):1354-1363. PubMed ID: 36622529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.